Mechanisms of Inactivation of HSV-2 during Storage in Frozen and Lyophilized Forms
- 5 September 2008
- journal article
- research article
- Published by Wiley in Biotechnology Progress
- Vol. 21 (3) , 911-917
- https://doi.org/10.1021/bp049601a
Abstract
The structural integrity of herpes simplex virus 2 (HSV-2) during freezing, thawing, and lyophilization has been studied using scanning and transmission electron microscopy. Viral particles should be thawed quickly from -80 to 37 degrees C to avoid artifacts of thawing. To avoid freezing damage, the virus should be rapidly frozen (>20 K s(-1)) rather than slowly frozen as occurs on the shelf of a lyophilizer (<1 K s(-1)). Fast freezing and thawing allows six cycles of freeze thaw with no loss of viral titer TCID50. Viral particles were characterized using immunogold labeling methods. Freshly thawed virus had 19 +/- 4 polyclonal immunogold particles virus(-1); virus stored at -80 degrees C for at least 4 months had 17 +/- 3 particles virus(-1); virus stored for 1 week at 4 degrees C had 8 +/- 4 particles virus(-1). By bulk lyophilization the number of particles was 4 +/- 4, but by fast freezing and lyophilization the number of gold particles improved to 12 +/- 5. The loss of viral membrane was directly observed, and the in vitro loss was demonstrated to occur through three possible pathways, including (i) simultaneous release of tegument and membrane, (ii) sequential release of membrane and then tegument, and (iii) release like by in vivo infection. The capsids were not further degraded as indicated by the lack of free DNA, which was only released by boiling the viral samples with 1% SDS, followed by a dilution to 0.001% w/v SDS for the real-time PCR reaction.Keywords
This publication has 25 references indexed in Scilit:
- Immobilization of Nonviral Vectors During the Freezing Step of LyophilizationJournal of Pharmaceutical Sciences, 2004
- Hydrogen/deuterium exchange of hydrophobic peptides in model membranes by electrospray ionization mass spectrometryJournal of the American Society for Mass Spectrometry, 2002
- Delivery of Herpes Simplex Virus Vectors through Liposome FormulationMolecular Therapy, 2001
- Active Immunization in the United States: Developments over the Past DecadeClinical Microbiology Reviews, 2001
- Formulation, Stability, and Delivery of Live Attenuated Vaccines for Human UseCritical Reviews in Therapeutic Drug Carrier Systems, 1999
- Freeze-drying of bioproducts: putting principles into practiceEuropean Journal of Pharmaceutics and Biopharmaceutics, 1998
- Disabled Infectious Single Cycle (DISC) Herpes Simplex Virus as a Vector for Immunotherapy of CancerPublished by Springer Nature ,1998
- A Genetically Inactivated Herpes Simplex Virus Type 2 (HSV-2) Vaccine Provides Effective Protection against Primary and Recurrent HSV-2 DiseaseThe Journal of Infectious Diseases, 1997
- Low-Temperature Microscopy and AnalysisPublished by Springer Nature ,1992
- Cryopreservation of Varicella-Zoster Virions without Loss of Structural Integrity or InfectivityIntervirology, 1981